Alphabet Inc
OBX icon

Alphabet Inc’s Obsidian Therapeutics OBX Stock Holding History

Alphabet Inc’s Portfolio OBX Stock Details OBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.8M Buy
+1,224,869
New +$23.9M 0.02% 20

Other funds holding OBX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Revelation Capital Management
Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Alphabet Inc's OBX Position: Q3 2026 in Review

Alphabet Inc opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 1,224,869 shares worth $16.8M. The stake represents 0.02% of the portfolio and ranks #20 among its holdings.

8 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • Alphabet Inc held 1,224,869 shares of Obsidian Therapeutics worth $16.8M as of Q3 2026.
  • Obsidian Therapeutics was a new Alphabet Inc position in Q3 2026.
  • Obsidian Therapeutics made up 0.02% of Alphabet Inc's portfolio in Q3 2026, its #20 holding.
  • 8 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on Alphabet Inc's 13F filing for Q3 2026, filed 6 Nov 2026.